Delivery Order SPE2DB22D2211-SPE2DB23FPFC3
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $10,354.97 for the supply of Naltrexone 50 mg tablets. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price, valued at $8,548.77, for the supply of 90-tablet bottles of the drug Naltrexone 50 mg. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4556776186 - Naltrexone 50 MG Tablet, 100S. The ceiling value of the Delivery Order is $1,772.35. The contract has an ultimate completion date of April 5, 2022 and was awarded on April 4, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,205.96, is for the delivery of Naltrexone 50 mg tablets. This is a firm fixed-price delivery order contract that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Naltrexone 50 mg tablets over a 2-year period ending in June 2024. The contract is a Delivery Order with a Firm Fixed Price of $1,356.78 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,370.20 firm fixed-price delivery order is for the supply of 60-count Naltrexone 50 mg tablets. The contract has an ultimate completion date of September 11, 2024 and is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,545.05 firm-fixed-price delivery order is for the supply of 60-count bottles of 50 mg Naltrexone tablets, a medication used to treat opioid and alcohol dependence. The award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,018.51, is a delivery order for the supply of 4,566,295,719 units of Naltrexone 50 mg tablets. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This contract award is for the supply of Naltrexone 50 mg tablets to the Defense Logistics Agency (DLA). The $1,562.28 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 22, 2024, with a completion date of June 24, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of naltrexone 50 mg tablets (90 count) to the Defense Logistics Agency (DLA). The $1,063.84 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 6, 2022, with a completion date of December 7, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds two significant Indefinite...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB23FPFC3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,262.38 for the supply of 30-count bottles of 50 mg Naltrexone tablets. The award was made by the Defense Logistics Agency (DLA) and does not include any set-aside designations, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide. This delivery order is issued under that larger IDC contract, enabling the DLA to efficiently procure essential medications and medical commodities to meet the healthcare needs of the U.S. Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 9/20/23 |